Abstract
Fluorescein diacetate (FDA) assay has been widely applied in coastal research to quantify microbial activity in sediments. However, the present FDA assay procedures embodied in sediment studies potentially include operational errors since the protocol was established for studies of terrestrial soil. In the present study, we optimised the procedure of FDA assay using sandy and cohesive sediments to improve experiential sensitivity and reproducibility. The optimised method describes quantitative measurement of the fluorescein produced when 1.0 g of fresh sediment is incubated with 50 mM phosphate buffer solution (pH: 7.3) and glass beads (2 g) at 35 °C for 1 h under a rotation of 50 rpm. The covariation coefficient of the optimised method ranged from 1.9% to 3.8% and the method sensitivity ranged from 0.25 to 1.57. The improved protocol provides a more reliable measurement of the FDA hydrolysis rate over a wide range of sediments compared to the original method.
| Original language | English |
|---|---|
| Pages (from-to) | 424-431 |
| Number of pages | 8 |
| Journal | Marine Pollution Bulletin |
| Volume | 110 |
| Issue number | 1 |
| DOIs | |
| State | Published - 15 Sep 2016 |
| Externally published | Yes |
Keywords
- Coastal sediment
- Enzyme assay
- Fluorescein diacetate
- Microbial activity
- Optimisation